AHA Recommends AI Medical Device Safeguards to FDA
A leading healthcare association is urging U.S. regulators to establish standards and benchmarks to assess the impact of medical devices and tools that utilize artificial intelligence (AI).
According to reports, the American Hospital Association (AHA) has recommended that the FDA support the development of an AI policy framework. This framework aims to promote future technology innovations while ensuring appropriate safeguards to protect privacy and patient security.
Significant Growth of AI in Healthcare
The AHA emphasizes that, within the past three years, the use of AI-enabled devices in healthcare settings has experienced considerable growth. These devices have the potential to enhance the efficiency and delivery of patient care. Notably, there has been an uptick in their application in diagnostic imaging and radiology, where AI technology can swiftly identify image patterns and anomalies that might evade human detection.
Importance of Compliance in AI Development
As the integration of AI technology in healthcare continues to expand, the focus on compliance becomes increasingly critical. The journey to becoming a proficient compliance engineering professional involves continuous learning, practical skill development, and a steadfast commitment to ensuring product safety, regulatory compliance, and maintaining the highest standards of professional integrity.
The AHA represents nearly 5,000 hospitals and 43,000 individual members across the U.S., highlighting its significant role in advocating for healthcare standards.
For further insights, the original report can be explored through various news outlets.
